POLE and colorectal carcinoma: First identified and reported in 2–6% of colorectal carcinomas [2, 9, 10], POLE mutations were also noted at frequencies of 6–9% amongst uterine corpus endometrial cancers [1, 11] and in gastric adenocarcinoma [12].